Metabolic Alterations in Different Stages of Hypertension in an Apparently Healthy Nigerian Population

Table 2

Comparison of components of MS among BP groups.

Variables	BP Group	Value	BP group	Value	𝑃
SBP (mmHg)	Normotension	107.4±4.8	Pre-HTN	122.0±6.4	<0.001^†
	Normotension	107.4±4.8	Stage 1 HTN	139.0±8.6	<0.001^†
	Normotension	107.4±4.8	Stage 2 HTN	170.1±25.5	<0.001^†
	Pre-HTN	122.0±6.4	Stage 1 HTN	139.0±8.6	<0.001^†
	Pre-HTN	122.0±6.4	Stage 2 HTN	170.1±25.5	<0.001^†
	Stage 1 HTN	139.0±8.6	Stage 2 HTN	170.1±25.5	<0.001^†
DBP (mmHg)	Normotension	69.4±2.9	Pre-HTN	76.6±5.0	<0.001^†
	Normotension	69.4±2.9	Stage 1 HTN	85.9±6.2	<0.001^†
	Normotension	69.4±2.9	Stage 2 HTN	102.5±12.8	<0.001^†
	Pre-HTN	76.6±5.0	Stage 1 HTN	85.9±6.2	<0.001^†
	Pre-HTN	76.6±5.0	Stage 2 HTN	102.5±12.8	<0.001^†
	Stage 1 HTN	85.9±6.2	Stage 2 HTN	102.5±12.8	<0.001^†
WC (cm)	Normotension	88.2±12.0	Pre-HTN	92.6±13.6	0.002^†
	Normotension	88.2±12.0	Stage 1 HTN	98.5±12.4	<0.001^†
	Normotension	88.2±12.0	Stage 2 HTN	102.0±12.7	<0.001^†
	Pre-HTN	92.6±13.6	Stage 1 HTN	98.5±12.4	<0.001^†
	Pre-HTN	92.6±13.6	Stage 2 HTN	102.0±12.7	<0.001^†
FPG (mmol/L)	Normotension	4.7±1.4	Stage 2 HTN	5.0±1.9	0.042^†
	Stage 1 HTN	4.6±0.9	Stage 2 HTN	5.0±1.9	0.034^†
TG (mmol/L)	Normotension	0.7±0.3	Stage 1 HTN	0.8±0.4	0.047^†
	Normotension	0.7±0.3	Stage 2 HTN	0.9±0.4	0.001^†
	Pre-HTN	0.8±0.4	Stage 2 HTN	0.9±0.4	0.047^†

𝑃: probability, ^†: significant, values are in mean ± s.d, 𝑛: number of participants, BP: blood pressure, SBP: systolic blood pressure, DBP: diastolic blood pressure, WC: waist circumference, TG: Triglyceride, FPG: fasting plasma glucose, MS: metabolic syndrome, HTN: hypertension, number of participants in normotension, pre-HTN, stage 1 HTN, stage 2 HTN groups = 143, 197, 114, 80, respectively; total number of participants = 534.